Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Certoparin versus unfractionated heparin for venous thromboembolism prophylaxis in acutely ill hospitalized medical patients
2006-004676-12Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in venous thromboembolism (VTE) comparing Certoparin arm with Unfractionated heparin arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jan 2007; status: completed.
02
Drugs
certoparinheparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2006-004676-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004676-12.